Given that CSCs and EMT phenotypes are the two cellular fractions that are most associated with aggressiveness, cellular heterogeneity, metastasis and therapy resistance of cancer, it raises the importance of CD73 and PD-L1 as potential promising drug targets in GBC. The gene discussed is CD274; the disease is cancer.